Wauthier-Braine, Belgium

Robert Kiss


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 35(Granted Patents)


Location History:

  • Castres, FR (1993)
  • Brussels, BE (1997 - 2003)
  • Wauthier-Braine, BE (1997 - 2004)

Company Filing History:


Years Active: 1993-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Kiss

Introduction

Robert Kiss is a notable inventor based in Wauthier-Braine, Belgium. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on developing compounds with therapeutic applications, particularly in the treatment of cancer.

Latest Patents

Among his latest patents are the "Phenanthroline-7-one derivatives and their therapeutic uses," which describes a pharmaceutical composition that includes an effective amount of specific compounds. These compounds exhibit interesting cytotoxic properties, leading to their potential use as antitumoral medicines. Another significant patent is for "Pharmaceutical compositions comprising 4-quinolones for treating cancers." This non-cytotoxic composition targets the proliferation of clonogenic cells in malignant tumors, showcasing his innovative approach to cancer treatment.

Career Highlights

Throughout his career, Robert Kiss has worked with reputable companies such as Pierre Fabre Medicament and Laboratoire L. Lafon. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical science.

Collaborations

Robert has collaborated with esteemed colleagues, including Francis Darro and Armand Frydman. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Robert Kiss stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing innovative treatments for cancer. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…